Exothera
Provider of contract manufacturing and development services intended to design and deliver affordable viral vector-based vaccines and cell and gene therapies. The company capitalizes on novel manufact...
Valuation
$108.4M
Market implied
Share Price
N/A
Total Raised
$69.5M
Last Round
N/A